Abstract
Although rates of sexual activity and function have been noted to decline over time in gynecologic cancer populations, it is important not to presume that sexuality is an insignificant aspect of life for older adults. The sexual and vaginal health impact of cancer treatment can be devastating for women of all ages. Disease type, stage of disease, and type of treatment can contribute to vaginal atrophy and sexual difficulties in female cancer patients, and particular gynecologic cancer diagnoses may present their own unique challenges. Regardless of the type or extent of surgery, surgical scars are constant reminders of a woman’s cancer experience and can influence her view of herself. Unfortunately, the epidemiology of sexual dysfunction in female cancer populations has not been extensively studied, and future clinical trials focusing on age, race, ethnicity, and treatment factors are needed. Vaginal health issues are especially problematic for all women with advancing age; however, there are many simple strategies to alleviate vaginal estrogen deprivation symptoms, but this information needs to be delivered to our patients. Maintaining overall vaginal health is crucial for comfort, especially since gynecological and pelvic examinations are a necessary part of routine care and cancer surveillance. Despite positive changes in the oncology and sexual medicine fields over the past several decades, past several decades, there is still a paucity of targeted and a paucity of targeted interventions addressing sexual and vaginal health issues. Prospective research with uniform measures and methods are needed to fully comprehend the impact of gynecologic cancer on the sexual function and vaginal health of women of all ages coping with cancer.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010;60: 277–300.
Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. JAMA. 1999;281:537–44.
Matlonis UA, Kornblith A, Lee H, et al. Long-term adjustment of early-stage ovarian cancer survivors. Int J Gynecol Cancer. 2008;18:1183–93.
Lindau ST, Schumm LP, Laumann EO, et al. A study of sexuality and health among older adults in the United States. N Engl J Med. 2008;357:762–74.
Palacios S, Castaño R, Grazziotin A. Epidemiology of female sexual dysfunction. Maturitas. 2009;63:119–23.
Carter J, Goldfrank D, Schover LR. Simple strategies for vaginal health promotion in cancer survivors. J Sex Med. 2011;8:549–59.
Schover LR. Counseling cancer patients about changes in sexual function. Oncology (Williston Park). 1999;13:1585–91; discussion 1591–2, 1595–6.
Katz A. Breaking the silence on cancer and sexuality: a handbook for healthcare providers. Pittsburgh: Oncology Nursing Society; 2007.
Onujiogu N, Johnson T, Seo S, et al. Survivors of endometrial cancer: who is at risk for sexual dysfunction? Gynecol Oncol. 2011;123:356–9.
Carter J, Raviv L, Applegarth L, et al. A cross-sectional study of the psychosocial impact of cancer-related infertility in women-Third-party reproductive assistance. J Cancer Surviv. 2010;4:236–46.
Lindau ST, Gavrilova N, Anderson D. Sexual morbidity in very long term survivors of vaginal and cervical cancer: a comparison to national norms. Gynecol Oncol. 2007;106:413–8.
Stead ML, Brown JM, Fallowfield L, et al. Lack of communication between healthcare professionals and women with ovarian cancer about sexual issues. Br J Cancer. 2003;88:666–71.
Wiggins DL, Wood R, Granai CO, et al. Sex, intimacy, and the gynecologic oncologists: survey results of the New England Association of Gynecologic Oncologists (NEAGO). J Psychosoc Oncol. 2007;25:61–70.
Hordern AJ, Street AF. Communicating about patient sexuality and intimacy after cancer: mismatched expectations and unmet needs. Med J Aust. 2007;186:224–7.
Rogers M, Todd C. Information exchange in oncology outpatient clinics: source, valence and uncertainty. Psychooncology. 2002;11:336–45.
Detmar SB, Muller MJ, Schornagel JH, et al. Health-related quality-of-life assessments and patient-physician communication: a randomized controlled trial. JAMA. 2002;288:3027–34.
Carter J, Sonoda Y, Chi DS, et al. Radical trachelectomy for cervical cancer: postoperative physical and emotional adjustment concerns. Gynecol Oncol. 2008;111:151–7.
Carter J, Raviv L, Sonoda Y, et al. Recovery issues of fertility-preserving surgery in patients with early-stage cervical cancer and a model for survivorship: the physician checklist. Int J Gynecol Cancer. 2011;21:106–16.
Rutledge TL, Heckman SR, Qualls C, et al. Pelvic floor disorders and sexual function in gynecologic cancer survivors: a cohort study. Am J Obstet Gynecol. 2010;203:514.e1–7.
Barakat RR, Markman M, Randall ME. Principles and practice of gynecologic oncology. 5th ed. Baltimore: Lippincott, Williams & Wilkins; 2009.
U.S. Cancer Statistics Working Group. United States cancer statistics: 1999–2007 incidence and mortality web-based report. Atlanta: Department of Health and Human Services, Centers for Disease Control and Prevention, and National Cancer Institute; 2010. Available at: http://www.cdc.gov/uscs.
Schover LR. Premature ovarian failure and its consequence: vasomotor symptoms, sexuality, and fertility. J Clin Oncol. 2008;26:753–8.
Hughes Jr CL, Wall LL, Creasman WT. Reproductive hormone levels in gynecologic oncology patients undergoing surgical castration after spontaneous menopause. Gynecol Oncol. 1991;40:42–5.
Finch A, Narod SA. Quality of life and health status after prophylactic salpingo-oophoretomy in women who carry a BRCA mutation: a review. Maturitas. 2011;70:261–5.
Wenzel L, Penson RT, Carter J, et al. Quality of life issues in gynecologic oncology. In: Barakat RR, Markman M, Randall ME, editors. Principles and practice of gynecologic oncology. 5th ed. Baltimore: Lippincott, Williams & Wilkins; 2009.
Casey C, Chen L, Rabow MW. Symptom management in gynecologic malignancies. Expert Rev Anticancer Ther. 2011;11:1077–89.
American Diabetes Association. Diabetes statistics. http://www.diabetes.org/diabetes-basics/diabetes-statistics/. Accessed October 15, 2012.
Bakhru A, Buckanovich RJ, Griggs JJ. The impact of diabetes on survival in women with ovarian cancer. Gynecol Oncol. 2011;121:106–11.
Yancik R, Havlik RJ, Wesley MN, et al. Cancer and comorbidity in older patients: a descriptive profile. Ann Epidemiol. 1996;6:399–412.
Nowosielski K, Violetta S. Mediators of sexual functions in women with diabetes. J Sex Med. 2011;8:2532–45.
Martelli V, Valisella S, Moscatiello S, et al. Prevalence of sexual dysfunction among postmenopausal women with and without metabolic syndrome. J Sex Med. 2012;9:434–41. Epub 2011 Oct 24.
Esposito K, Maiorino MI, Bellastella G, et al. Determinants of female sexual dysfunction in type 2 diabetes. Int J Impot Res. 2010;22:179–84.
Erol B, Tefekli A, Ozbey I, et al. Sexual dysfunction in type II diabetic females: a comparative study. J Sex Marital Ther. 2002;28 Suppl 1:55–62.
Rockliffe-Fidler C, Kiemle G. Sexual function in diabetic women: a psychological perspective. Sex Relat Ther. 2003;18:143–59.
Enzlin P, Rosen R, Wiegel M, DCCT.EDIC Research Group, et al. Sexual dysfunction in women with type 1 diabetes: long-term findings from the DCCT/EDIC study cohort. Diabetes Care. 2009;32:780–5.
Orlarinoye J, Olarinoye A. Determinants of sexual function among women with type 2 diabetes in a Nigerian population. J Sex Med. 2008;5:878–86.
Ogbera AO, Chinenye S, Akinlade A, et al. Frequency correlates of sexual dysfunction in women with diabetes mellitus. J Sex Med. 2009;6:3401–6.
Enzlin P, Mathieu C, Van den Bruel A, et al. Sexual dysfunction in women with type 1 diabetes: A controlled study. Diabetes Care. 2002;25:672–7.
Hughes MK. Alterations of sexual function in women with cancer. Semin Oncol Nurs. 2008;24:91–101.
Pignata S, De Placido S, Biamonte R, et al. Residual neurotoxicity in ovarian cancer patients in clinical remission after first-line chemotherapy with carboplatin and paclitaxel: the Multicenter Italian Trial in Ovarian Cancer (MITO-4) retrospective study. BMC Cancer. 2006;6:5.
Dunton CJ. Management of treatment-related toxicity in advanced ovarian cancer. Oncologist. 2002;7 Suppl 5:11–9.
Armstrong DK, Bundy B, Wenzel L, et al. Intraperitoneal cisplatin and paclitaxel in ovarian cancer. N Engl J Med. 2006;354:34–43.
Wenzel LB, Huang HQ, Armstrong DK, et al. Baseline quality of life (QOL) as a predictor of tolerance to intraperitoneal (IP) chemotherapy for advanced epithelial ovarian cancer (EOC): a Gynecologic Oncology Group (GOG) study. Paper ASCO annual meeting proceedings. J Clin Oncol. 2006;24:Abs 5007.
Krychman M, Pereira L, Carter J. Sexual oncology: sexual health issues in women with cancer. Oncology. 2006;71:18–25.
Kitchener H, Swart AMC, Qian W, et al. Efficacy of systemic pelvic lymphadenctomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet. 2009;373:125.
Panici PB, Basile S, Maneschi F, et al. Systematic pelvic lymphadenectomy vs no lymphadenectomy in early-stage endometrial carcinoma: ramdonized clinical trial. J Natl Cancer Inst. 2009;100:1707.
Walker JL, Piedmonte MR, Spirtos NM, et al. Laparoscopy compared with laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group study LAP2. J Clin Oncol. 2009;27:5331–6.
de Kroon CD, Gaarenstroom KN, van Poelgeest M, et al. Nerve sparing in radical surgery for early-stage cervical cancer: yes we should! Int J Gynecol Cancer. 2010;20(S2):39–41.
Harris PF, Remington PL, Trentham-Dietz A, Allen CI, et al. Prevalence and treatment of menopausal symptoms among breast cancer survivors. J Pain Symptom Manage. 2002;23: 501–9.
Crandall C, Petersen L, Ganz PA, et al. Association of breast cancer and its therapy with menopause-related symptoms. Menopause. 2004;11:519–30.
Gupta P, Sturdee DW, Palin SL, et al. Menopausal symptoms in women treated for breast cancer: the prevalence and severity of symptoms and their perceived effects on quality of life. Climacteric. 2006;9:49–58.
Ganz PA, Greendale GA, Petersen L, et al. Breast cancer in younger women: reproductive and late health effects of treatment. J Clin Oncol. 2003;21:4184–93.
Alektiar KM, Venkatraman E, Chi DS, et al. Intravaginal brachytherapy alone for intermediate-risk endometrial cancer. Int J Radiat Oncol Biol Phys. 2005;62:111–7.
Bergmark K, Avall-Lundqvist E, Dickman PW, et al. Vaginal changes and sexuality in women with a history of cervical cancer. N Engl J Med. 1999;340:1383–9.
Saibishkumar EP, Patel FD, Sharma SC. Evaluation of late toxicities of patients with carcinoma of the cervix treated with radical radiotherapy: an audit from India. Clin Oncol. 2006;18:30–7.
Flay LD, Matthews JH. The effects of radiotherapy and surgery on the sexual function of women treated for cervical cancer. Int J Radiat Oncol Biol Phys. 1995;31:399–404.
Bruner DW, Lanciano R, Keegan M, et al. Vaginal stenosis and sexual function following intracavitary radiation for the treatment of cervical and endometrial carcinoma. Int J Radiat Oncol Biol Phys. 1993;27:825–30.
Jensen P, Groenvold M, Klee M, et al. Longitudinal study of sexual function and vaginal changes after radiotherapy for cervical cancer. Int J Radiat Oncol Biol Phys. 2003;56:937–49.
Creutzberg CL, van Putten WL, Koper PC, et al. The morbidity of treatment for patients with stage I endometrial cancer: results from a randomized trial. Int J Radiat Oncol Biol Phys. 2001;51:1246–55.
Nout RA, Putter H, Jürgenliemk-Schulz IM, et al. Quality of life after pelvic radiotherapy or vaginal brachytherapy for endometrial cancer: first results of the randomized PORTEC-2 trial. J Clin Oncol. 2009;27:3547–56.
Petereit DG, Tannehill SP, Grosen EA, et al. Outpatient vaginal cuff brachytherapy for endometrial cancer. Int J Gynecol Cancer. 1999;9:456–62.
Anderson JM, Stea B, Hallum AV, et al. High-dose-rate postoperative vaginal cuff irradiation alone for stage IB and IC endometrial cancer. Int J Radiat Oncol Biol Phys. 2000;46:417–25.
MacLeod C, Fowler A, Duval P, et al. High-dose-rate brachytherapy alone post-hysterectomy for endometrial cancer. Int J Radiat Oncol Biol Phys. 1998;42:1033–9.
Kumar VJ, Nin CY, Kuei LY, et al. Survival and disease relapse in surgical stage I endometrioid adenocarcinoma of the uterus after adjuvant vaginal vault brachytherapy. Int J Gynecol Cancer. 2010;20:564–9.
Nout RA, Smit VT, Putter H, et al. Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial. Lancet. 2010;375:816–23.
Likes WM, Stegbauer C, Tillmanns T, et al. Correlates of sexual function following vulvar excision. Gynecol Oncol. 2007;105:600–3.
Burke TW, Stringer CA, Gershenson DM, et al. Radical wide excision and selective inguinal node dissection for squamous cell carcinoma of the vulva. Gynecol Oncol. 1990;38:328–32.
Berman ML, Soper JT, Creasman WT, et al. Conservative surgical management of superficially invasive stage I vulvar carcinoma. Gynecol Oncol. 1989;35:352–7.
Hacker NF, Leuchter RS, Berek JS, et al. Radical vulvectomy and bilateral inguinal lymphadenectomy through separate groin incisions. Obstet Gynecol. 1981;58:574–9.
Abu-Rustum NR, Alektiar K, Iasonos A, et al. The incidence of symptomatic lower-extremity lymphedema following treatment of uterine corpus malignancies: a 12-year experience at Memorial Sloan-Kettering Cancer Center. Gynecol Oncol. 2006;103:714–8.
Center for Disease Control and Prevention (CDC). Human papillomavirus. Rockville: National Prevention Network; 2009. www.CDC.gov/aging.
Howlader N, Noone AM, Krapcho M, Neyman N, et al. (eds.), SEER cancer statistics review, 1975–2009. Bethesda: National Cancer Institute; 2011. Available: http://seer.cancer.gov/csr/1975_2009_pops09/ Accessed on 2012.
Montgomery K, Bloch JR, Bhattacharya A. Human papillomavirus and cervical cancer knowledge, health beliefs, and preventative practices in older women. J Obstet Gynecol Neonatal Nurs. 2010;39:238–49.
Chan PK, Chang AR, Yu MY, et al. Age distribution of human papillomavirus infection and cervical neoplasia reflects caveats of cervical screening policies. Int J Cancer. 2010;26: 297–301.
Saslow D, Runowicz C, Solomon D, et al. American Cancer Society guideline for the early detection of cervical neoplasia and cancer. CA Cancer J Clin. 2002;52:342–62.
Jensen PT, Groenvold M, Klee MC, et al. Early-stage cervical carcinoma, radical hysterectomy, and sexual function – a longitudinal study. Cancer. 2004;100:97–106.
Pieterse QD, Maas CP, ter Kuile MM, et al. An observational longitudinal study to evaluate miction, defecation, and sexual function after radical hysterectomy with pelvic lymphadenectomy for early-stage cervical cancer. Int J Gynecol Cancer. 2006;16:1119–29.
Ditto A, Martinelli F, Borreani C, et al. Quality of life and sexual, bladder, and intestinal dysfunctions after class III nerve-sparing and class II radical hysterectomies: a questionnaire-based study. Int J Gynecol Cancer. 2009;19:953–7.
Roth AJ, Carter J, Nelson CJ. Sexuality after cancer. In: Holland JC, Breitbart WS, Jacobsen PB, et al., editors. Psycho-oncology. 2nd ed. New York: Oxford University Press, Inc.; 2010. p. 245–50.
Schover L, Fife M, Gershenson D. Sexual dysfunction and treatment for early stage cervical cancer. Cancer. 1989;63:204–12.
White I. The assessment and management of sexual difficulties after treatment of cervical and endometrial malignancies. Clin Oncol. 2008;20:488–96.
Denton AS, Maher EJ. Interventions for the physical aspects of sexual dysfunction in women following pelvic radiotherapy. Cochrane Database Syst Rev. 2003;(1):CD003750.
Katz A. Interventions for sexuality after pelvic radiation therapy and gynecological cancer. Cancer J. 2009;15:45–7.
Katz A, Njuguna E, Rakowsky E, et al. Early development of vaginal shortening during radiation therapy for endometrial or cervical cancer. Int J Gynecol Cancer. 2001;11:234–5.
Brand AH, Bull CA, Cakir B. Vaginal stenosis in patients treated with radiotherapy for carcinoma of the cervix. Int J Gynecol Cancer. 2006;16:288–93.
Decruze SB, Guthrie D, Magnani R. Prevention of vaginal stenosis in patients following vaginal brachytherapy. Clin Oncol. 1999;11:46–8.
Wenzel L, DeAlba I, Habbal R, et al. Quality of life in long-term cervical cancer survivors. Gynecol Oncol. 2005;97:310–7.
Frumovitz M, Sun CC, Schover LR, et al. Quality of life and sexual functioning in cervical cancer survivors. J Clin Oncol. 2005;23:7428–36.
Greimel ER, Winter R, Kapp KS, et al. Quality of life and sexual functioning after cervical cancer treatment: a long-term follow-up study. Psychooncology. 2009;18:476–82.
Benn T, Brooks RA, Zhang Q, et al. Pelvic exenteration in gynecologic oncology: a single institution study over 20 years. Gynecol Oncol. 2011;122:14–8.
Carter J, Chi DS, Abu-Rustum NR, et al. Brief report: Total pelvic exenteration – a retrospective clinical needs assessment. Psychooncology. 2004;13:125–31.
Maggioni A, Roviglione G, Landoni F, et al. Pelvic exenteration: ten-year experience at the European Institute of Oncology in Milan. Gynecol Oncol. 2009;114:64–8.
Pusic AL, Mehrara BJ. Vaginal reconstruction: an algorithm approach to defect classification and flap reconstruction. J Surg Oncol. 2006;94:515–21.
Cullivan R, Crown J, Walsh N. The use of psychotropic medication in patients referred to a psycho-oncology service. Psychooncology. 1998;7:301–6.
Kim HF, Fisch MJ. Antidepressant use in ambulatory cancer patients. Curr Oncol Rep. 2006;8:275–81.
Wernecke U, Northey S, Bhugra D. Antidepressants and sexual dysfunction. Acta Psychiatr Scand. 2006;114:386–97.
Balon R. SSRI-associated sexual dysfunction. Am J Psychiatry. 2006;163:1504–9.
Kagan SH, Holland N, Chalian AA. Sexual issues in special populations: geriatric oncology – sexuality and older adults. Semin Oncol Nurs. 2008;24:120–6.
Corney RH, Crowther ME, Everett H, et al. Psychosexual dysfunction in women with gynaecological cancer following radical pelvic surgery. Br J Obstet Gynaecol. 1993;100:73–8.
Anderson BL, Woods XA, Copeland LJ. Sexual self-schema and sexual morbidity among gynecologic cancer survivors. J Consult Clin Psychol. 1997;65:221–9.
Carpenter KM, Anderson BL, Fowler JM, et al. Sexual self schema as a moderator of sexual and psychological outcomes for gynecologic cancer survivors. Arch Sex Behav. 2009;38:828–41.
Lees J, Chan A. Polypharmacy in elderly patients with cancer: clinical implications and management. Lancet Oncol. 2011;12(13):1249–57. Epub 2011 Jul 6.
Labrie F, Archer D, Bouchard C, et al. Effect of intravaginal dehydroepiandrosterone (Prasterone) on libido and sexual dysfunction in postmenopausal women. Menopause. 2009;16:923–31.
North American Menopause Society. Position Statement: estrogen and progestogen use in postmenopausal women: 2010 position statement of The North American Menopause Society. Menopause J North Am Menopause Soc. 2010;17(2):242–55.
Ganz PA, Greendale GA, Kahn B, et al. Are older breast carcinoma survivors willing to take hormone replacement therapy? Cancer. 1999;86:814–20.
Biglia N, Cozzarella M, Cacciari F, et al. Menopause after breast cancer: a survey on breast cancer survivors. Maturitas. 2003;45:29–38.
van der Laak JA, de Bie LM, de Leeuw H, et al. The effect of Replens on vaginal cytology in the treatment of postmenopausal atrophy: cytomorphology versus computerised cytometry. J Clin Pathol. 2002;55:446–51.
Ekin M, Yasar L, Savan K, et al. The comparison of hyaluronic acid vaginal tablets with estradiol vaginal tablets in the treatment of atrophic vaginitis: a randomized controlled trial. Arch Gynecol Obstet. 2011;283:539–43.
Constantino D, Guaraldi C. Effectiveness and safety of vaginal suppositories for the treatment of the vaginal atrophy in postmenopausal women: an open, non-controlled clinical trial. Eur Rev Med Pharmacol Sci. 2008;12:411–6.
Friedman LC, Abdallah R, Schluchter M, et al. Adherence to vaginal dilation following high dose rate brachytherapy for endometrial cancer. Int J Radiat Oncol Biol Phys. 2010;80(3):751–7. Epub 2010 Jul 7.
Rosenbaum TY. Pelvic floor involvement in male and female sexual dysfunction and the role of pelvic floor rehabilitation in treatment: a literature review. J Sex Med. 2007;4:4–13.
Goldfinger C, Pukall CF, Gentilcore-Saulnier E, et al. A prospective study of pelvic floor physical therapy: pain and psychosexual outcomes in provoked vestibulodynia. J Sex Med. 2009;6:1955–68.
Lowenstein L, Gruenwald I, Gartman I, et al. Can stronger pelvic muscle floor improve sexual function? Int Urogynecol J Pelvic Floor Dysfunct. 2010;21:553–6.
Groysman V. Vulvodynia: new concepts and review of the literature. Dermatol Clin. 2010;28:681–96.
Kornblith AB, Huang HQ, Walker JL, et al. Quality of life of patients with endometrial cancer undergoing laparoscopic international federation of gynecology and obstetrics staging compared with laparotomy: a Gynecologic Oncology Group study. J Clin Oncol. 2009;27:5337–42.
Baser RE, Carter J, Li Y. Psychometric validation of the Female Sexual Function Index (FSFI) in cancer survivors. Cancer. 2012;118(18):4606–18.
Isidori AM, Pozza C, Esposito K, et al. Development and validation of a 6-item version of the female sexual function index (FSFI) as a diagnostic tool for female sexual dysfunction. J Sex Med. 2010;7:1139–46.
Jeffery DD, Tzeng JP, Keefe FJ, et al. Initial report of the cancer patient-reported outcomes measurement information system (PROMIS) sexual function committee review of sexual function measures and domains used in oncology. Cancer. 2009;115:1142–53.
Flynn KE, Jeffrey DD, Keefe FJ, et al. Sexual functioning along the cancer continuum: focus group results from the Patient-Reported Outcomes Measurement Information System (PROMIS (R)). Psychooncology. 2011;20:378–86.
Flynn KE, Reese JB, Jeffrey D. Patient experiences with communication about sex during and after treatment for cancer. Psychooncology. 2012;21(6):594–601.
Goldfarb S, Abramsohn EM, Baron S, Carter J, Dickler M, Florendo J, Freeman L, Githen K, Makelarski J, Yamada SD, Lindau ST. Convening a national network to advance the field of cancer and female sexuality. Poster presentation at the cancer survivorship and sexual health symposium, Washington, D.C., June 2011.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag London
About this chapter
Cite this chapter
Stabile, C., Steed, R., Carter, J. (2013). Sexual Medicine in the Management of Older Gynecologic Cancer Patients. In: Lichtman, S., Audisio, R. (eds) Management of Gynecological Cancers in Older Women. Springer, London. https://doi.org/10.1007/978-1-4471-4605-6_21
Download citation
DOI: https://doi.org/10.1007/978-1-4471-4605-6_21
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-4471-2215-9
Online ISBN: 978-1-4471-4605-6
eBook Packages: MedicineMedicine (R0)